View in EDS

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.

Saved in:
Bibliographic Details
Title: The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.
Authors: Gehin JE; Department of Medical Biochemistry, Oslo University Hospital., Klaasen RA; Department of Medical Biochemistry, Oslo University Hospital., Kristianslund EK; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jyssum I; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Sexton J; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Warren DJ; Department of Medical Biochemistry, Oslo University Hospital., Aletaha D; Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria ; and., Haavardsholm EA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway ., Goll GL; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway ., Syversen SW; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway ., Bolstad N; Department of Medical Biochemistry, Oslo University Hospital.
Source: Therapeutic drug monitoring [Ther Drug Monit] 2026 Aug 01; Vol. 48 (4), pp. 481-486. Date of Electronic Publication: 2026 Feb 02.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41622540
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gehin+JE%22">Gehin JE</searchLink>; Department of Medical Biochemistry, Oslo University Hospital.<br /><searchLink fieldCode="AU" term="%22Klaasen+RA%22">Klaasen RA</searchLink>; Department of Medical Biochemistry, Oslo University Hospital.<br /><searchLink fieldCode="AU" term="%22Kristianslund+EK%22">Kristianslund EK</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jyssum+I%22">Jyssum I</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sexton+J%22">Sexton J</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Warren+DJ%22">Warren DJ</searchLink>; Department of Medical Biochemistry, Oslo University Hospital.<br /><searchLink fieldCode="AU" term="%22Aletaha+D%22">Aletaha D</searchLink>; Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria ; and.<br /><searchLink fieldCode="AU" term="%22Haavardsholm+EA%22">Haavardsholm EA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway .<br /><searchLink fieldCode="AU" term="%22Goll+GL%22">Goll GL</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway .<br /><searchLink fieldCode="AU" term="%22Syversen+SW%22">Syversen SW</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway .<br /><searchLink fieldCode="AU" term="%22Bolstad+N%22">Bolstad N</searchLink>; Department of Medical Biochemistry, Oslo University Hospital.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227909660%22">Therapeutic drug monitoring</searchLink> [Ther Drug Monit] 2026 Aug 01; Vol. 48 (4), pp. 481-486. <i>Date of Electronic Publication: </i>2026 Feb 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7909660 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1536-3694 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201634356%22">01634356 </searchLink><i>NLM ISO Abbreviation: </i>Ther Drug Monit <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41622540
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/FTD.0000000000001440
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 481
    Titles:
      – TitleFull: The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gehin JE
      – PersonEntity:
          Name:
            NameFull: Klaasen RA
      – PersonEntity:
          Name:
            NameFull: Kristianslund EK
      – PersonEntity:
          Name:
            NameFull: Jyssum I
      – PersonEntity:
          Name:
            NameFull: Sexton J
      – PersonEntity:
          Name:
            NameFull: Warren DJ
      – PersonEntity:
          Name:
            NameFull: Aletaha D
      – PersonEntity:
          Name:
            NameFull: Haavardsholm EA
      – PersonEntity:
          Name:
            NameFull: Goll GL
      – PersonEntity:
          Name:
            NameFull: Syversen SW
      – PersonEntity:
          Name:
            NameFull: Bolstad N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1536-3694
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Therapeutic drug monitoring
              Type: main
ResultId 1